Protagenic Therapeutics Inc (PTIX)
1.79
-0.03
(-1.65%)
USD |
NASDAQ |
Mar 28, 16:00
1.79
0.00 (0.00%)
After-Hours: 20:00
Protagenic Therapeutics Net Income (TTM): -3.926M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -3.926M |
June 30, 2023 | -3.454M |
March 31, 2023 | -2.912M |
December 31, 2022 | -3.556M |
September 30, 2022 | -3.844M |
June 30, 2022 | -3.798M |
March 31, 2022 | -4.679M |
December 31, 2021 | -4.523M |
September 30, 2021 | -4.156M |
June 30, 2021 | -4.324M |
March 31, 2021 | -3.344M |
December 31, 2020 | -2.636M |
September 30, 2020 | -2.862M |
June 30, 2020 | -1.939M |
March 31, 2020 | -1.650M |
December 31, 2019 | -1.751M |
September 30, 2019 | -1.791M |
June 30, 2019 | -2.165M |
March 31, 2019 | -2.558M |
December 31, 2018 | -2.557M |
September 30, 2018 | -2.463M |
June 30, 2018 | -2.420M |
March 31, 2018 | -2.200M |
December 31, 2017 | -2.260M |
September 30, 2017 | -2.120M |
Date | Value |
---|---|
June 30, 2017 | -2.120M |
March 31, 2017 | -2.194M |
December 31, 2016 | -2.276M |
September 30, 2016 | -1.878M |
June 30, 2016 | -1.553M |
March 31, 2016 | -1.141M |
December 31, 2015 | -0.52M |
September 30, 2015 | -0.495M |
June 30, 2015 | -0.476M |
March 31, 2015 | -0.46M |
December 31, 2014 | -0.711M |
September 30, 2014 | -0.798M |
June 30, 2014 | -1.08M |
March 31, 2014 | -5.506M |
December 31, 2013 | -11.29M |
September 30, 2013 | -14.58M |
September 30, 2011 | -22.35M |
June 30, 2011 | -21.47M |
March 31, 2011 | -19.81M |
December 31, 2010 | -19.73M |
September 30, 2010 | -35.51M |
June 30, 2010 | -34.26M |
March 31, 2010 | -31.72M |
December 31, 2009 | -29.47M |
September 30, 2009 | -122.08M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-4.679M
Minimum
Mar 2022
-1.650M
Maximum
Mar 2020
-3.151M
Average
-3.344M
Median
Mar 2021
Net Income (TTM) Benchmarks
Ekso Bionics Holdings Inc | -15.20M |
Eyenovia Inc | -27.26M |
NovaBay Pharmaceuticals Inc | -13.74M |
Palatin Technologies Inc | -31.59M |
iBio Inc | -27.28M |